Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404478 · ClinicalTrials.gov registry record · NA
Stress-reduction Wellness Program for Midlife Black Women (B-SWELL)
A NA study of Stress and Health Behavior, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT04404478: Completed NA study of Stress and Health Behavior, sponsored by University of Cincinnati.
NCT04404478 is a NA study of Stress and Health Behavior that has completed, run by University of Cincinnati. The registered enrollment target is 52 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04404478, a NA study of Stress and Health Behavior, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study examines the unique cultural and gender-based factors that influence how midlife Black women experience stress and incorporate healthy lifestyle behaviors into daily life. The B-SWELL intervention uses stress reduction and goal setting to increase self efficacy in adopting healthy lifestyle behaviors. The B-SWELL intervention will be compared to an inattention control wellness group in a randomized control trial. The long-term outcome is to decrease cardiovascular disease risk in this high-risk population, midlife Black women.
Primary Outcome
Life's Simple 7 score measures cardiovascular health. Minimum score is 0. Maximum score is 14. Each of the 7 metrics (weight loss, diet, exercise, cholesterol management, glucose management, smoking, and blood pressure management) is rated 0 (poor), 1 (average), or 2 (best). Higher scores indicate greater cardiovascular health. Lower scores indicate greater risk for heart disease.
Conditions Studied
Interventions
- BEHAVIORAL B-SWELL: Midlife Black Women's Stress Reduction Wellness Program
- BEHAVIORAL WE: Wellness program for Midlife Black Women
Study Locations (1)
Ohio
- University of Cincinnati, College of Nursing - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-02-13 |
| Est. Completion | 2021-06-12 |
| Phase | NA |
What the finished NCT04404478 record still lists
NCT04404478 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (93% lower).
The record links to 5 conditions, with Stress appearing as the primary indexed condition, and to 2 interventions - of which B-SWELL: Midlife Black Women's Stress Reduction Wellness Program is the first listed.
NCT04404478 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04404478 about?
NCT04404478 is a clinical study titled "Stress-reduction Wellness Program for Midlife Black Women (B-SWELL)". This research study examines the unique cultural and gender-based factors that influence how midlife Black women experience stress and incorporate healthy lifestyle behaviors into daily life. The B-SWELL intervention uses stress reduction and goal setting to increase self efficacy in adopting health...
What is the current status of trial NCT04404478?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2021-02-13. Estimated completion is 2021-06-12.
What conditions does trial NCT04404478 study?
This clinical trial studies the following conditions: Stress, Health Behavior, Depressive Symptoms, Cardiovascular Risk Factor, Self Efficacy.
What interventions are being tested in trial NCT04404478?
The interventions under investigation include: B-SWELL: Midlife Black Women's Stress Reduction Wellness Program (BEHAVIORAL), WE: Wellness program for Midlife Black Women (BEHAVIORAL).
Who is sponsoring clinical trial NCT04404478?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04404478 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04404478's enrollment target sits among peer trials
52 104th of 152 higher than 48 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI